Close on 09 Oct 2026
All US Equities (S&P 500 / NASDAQ-100)

Elevance Health

ELVUS Listed
Exchange: NYSE · Market: US Equities · Currency: USD

Elevance Health (ELV) is a leading publicly traded corporation listed in the United States, constituent of the S&P 500 index.

Sector: Health Care·Indices: S&P 500·Market Cap: $91.54B
Close on 16 Oct 2026
$428.26
-0.17 (-0.04%)
Last updated: 16 Oct 2026 (US Market EOD settlement)

Stock Snapshot & Key Numbers — Elevance Health

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Down -0.04% on 16 Oct 2026
Position vs 1-Year High
Near 52-Week High
P/E Valuation Multiple
18.7x (Under 20x)
Annual Cash Dividend
1.67% Dividend Yield
Close on 16 Oct 2026
$428.26
-0.17 (-0.04%)vs prev close
1-Year Low to High Range100% of range
Low: $281High: $428
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):18.7x
P/B Ratio (Price / Book):2.0x
Dividend Yield:1.67%
Total Company Value (Market Cap)
$91.54B
Sector: Health Care
Latest Official Announcement:HealthCare Global Enterprises Ltd (NSE:HCG) (Q1 2027) Earnings Call Highlights: Strong Revenue ... - Yahoo Finance Australia
2mo ago
Plain-English Company Summary

Elevance Health (ELV) is a US equity security listed on the NYSE. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at $428.26, recording a -0.17 (-0.04%) decline from its previous close of $428.43. Over the trailing 52-week trading cycle, ELV has traded between a 52-week low of $280.74 and a 52-week high of $428.43, establishing its annual trading channel. In historical performance, Elevance Health has gained 23% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +3.77%, 1-month: +3.81%, 6-month: +35.6%, 1-year: +23%, 3-year: -7.43%, 5-year: +10.32%. Daily reported trading volume reached 1,220,100 equity shares. On key valuation multiples as of Oct 13, 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 18.7x and a price-to-book (P/B) ratio of 2.0x, with a trailing dividend yield of 1.67%. Its market capitalization stands at $91.54B. The company is categorized under the Health Care sector and S&P 500 industry within the US equities universe.

Price Chart

1Y: +23.00% (₹80.08)
₹428₹378₹329₹281Thu, 16 Oct, 2025Fri, 16 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Range$280.74 – $428.43
Low: $280.74High: $428.43
$280.74$428.43
Trailing P/E Ratio18.68x
Price to Book (P/B)2.04x
Dividend Yield1.67%
Day High / Low$426.72 – $434.00
Daily Volume1.22M

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
1,234 past 21-day periods analyzed
Fell 21.7%
Within ±5% (53.9%)
Rose 24.4%
Fell > 5%
21.7%
268 windows
Within ±5%
53.9%
665 windows
Rose > 5%
24.4%
301 windows
In 80% of past 1 month windows the move was within ±9%.
Historical outcomes of this stock's own price. Not a forecast. (1255 trading days of history).
How to read historical odds

At-a-Glance Health & Momentum Check

Market Mood: Consolidation / Rangebound
News Activity
STABLE
Recent announcement pace
Profit & Margin Trend
EXPANDING
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Consolidation / Rangebound
Current market trend
News Tone
POSITIVE EXPANSION
Recent filing tone
What This Means(based on reported financials)

Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.

Active Risk Flags & Monitoring Constraints
Standard systemic equity market and interest rate cycle exposure

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 35.4% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
S&P 500+0.35+0.13Trailing 1Y historical sensitivity: a 1% move in S&P 500 coincided with a +0.35% co-movement (correlation: 0.13). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield-0.01+0.00Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.01% co-movement (correlation: -0.00). Descriptive historical relationship, not predictive.
Brent Crude Oil-0.05-0.08Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.05% co-movement (correlation: -0.08). Descriptive historical relationship, not predictive.
USD / INR-0.09-0.02Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.09% co-movement (correlation: -0.02). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹412.70₹428.26+3.77%
15 Days₹381.67₹428.26+12.21%
1 Month₹412.56₹428.26+3.81%
3 Months₹372.85₹428.26+14.86%
6 Months₹315.82₹428.26+35.60%
1 Year₹348.18₹428.26+23.00%
3 Years₹462.62₹428.26-7.43%
5 Years₹388.21₹428.26+10.32%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
35.4%
Annualized volatility
1Y Beta vs Index
0.35
vs benchmark index
Biggest 1Y Drop
-26.5%
1Y peak-to-low drop
Biggest 5Y Drop
-51.1%
5Y peak-to-low drop
vs 52W High
-0.0%
Distance from 1Y high
vs 52W Low
+52.5%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹354.25₹428.26+20.9%
CY 2025₹365.83₹350.55-4.2%
CY 2024₹478.83₹368.90-23.0%
CY 2023₹502.20₹471.56-6.1%
CY 2022₹464.86₹512.97+10.3%
CY 2021₹388.21₹463.54+19.4%

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for ELV.

Historical Investment Simulator

Factual simulation of past returns in Elevance Health (ELV) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹1,10,316.60
Based on latest close
Absolute Return
+10.3%
+₹10,316.60
Annualized (CAGR)
+2.0%
Compound annual growth
Entry Price: ₹388.21 · Exit Price: ₹428.26
Simulated 5Y period (INR)

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 2 of 2 Updates
#1 EARNINGSLODR Materiality: 91/100Positive Business DriverBackground Context
2mo ago

HealthCare Global Enterprises Ltd (NSE:HCG) (Q1 2027) Earnings Call Highlights: Strong Revenue ... - Yahoo Finance Australia

HealthCare Global Enterprises Ltd (NSE:HCG) (Q1 2027) Earnings Call Highlights: Strong Revenue ... Yahoo Finance Australia

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Inspecting in Causal Panel
Source: Yahoo Finance Australia·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#2 EARNINGSLODR Materiality: 82/100Neutral / RoutineBackground Context
5mo ago

Centene raises 2026 profit forecast on improving cost controls - Reuters

Centene raises 2026 profit forecast on improving cost controls Reuters

Valuation Impact:±1.0% (In-line Quarterly Disclosure)
Click to analyze
Source: Reuters·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 2
Causal Attribution in Focus
EARNINGS·2mo ago
Verified Exchange / Wire Disclosure:
HealthCare Global Enterprises Ltd (NSE:HCG) (Q1 2027) Earnings Call Highlights: Strong Revenue ... - Yahoo Finance Australia
Source: Yahoo Finance Australia·LODR Materiality: 91/100Tailwind
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Quarterly Financial Milestone & Operating Margins
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. ELV Accretion
+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Causal Attribution Analysis:Primary Value-Chain Beneficiary

Financial performance outpaced historical baseline, driving operating leverage and valuation re-rating.

Extracted Factual Evidence:
  • •Financial performance and operating margins expanded ahead of consensus projections
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across health care units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Operating EBITDA MarginRevenue VisibilityNet Income (PAT)
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

Common Questions About Elevance Health (ELV)

Key facts on ELV share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of Elevance Health (ELV)?

As of 16 Oct 2026, the official closing share price of Elevance Health (ELV) on NYSE is $428.26 (-0.04% vs the previous close). Over the past 52 weeks, ELV has traded between a low of $280.74 and a high of $428.43, with a reported market capitalization of $91.54B.

What are the historical returns of Elevance Health (ELV)?

Based on split-adjusted closing prices through 16 Oct 2026, Elevance Health (ELV) recorded the following trailing price returns: 1 Week: +3.77% (from $412.70 to $428.26); 15 Days: +12.21% (from $381.67 to $428.26); 1 Month: +3.81% (from $412.56 to $428.26); 3 Months: +14.86% (from $372.85 to $428.26); 6 Months: +35.60% (from $315.82 to $428.26); 1 Year: +23.00% (from $348.18 to $428.26); 3 Years: -7.43% (from $462.62 to $428.26); 5 Years: +10.32% (from $388.21 to $428.26). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of Elevance Health (ELV)?

Elevance Health (ELV) currently trades at a trailing Price-to-Earnings (P/E) ratio of 18.7x, a Price-to-Book (P/B) ratio of 2.0x, and a trailing 12-month dividend yield of 1.67%. It operates in the Health Care sector (S&P 500).

How much would a past lump-sum or monthly SIP investment in ELV have grown?

Based on historical closing prices for Elevance Health (ELV): A one-time lump-sum investment of $10000.00 held for 5 years would be worth $11031.66 (+10.3% total return, 2.0% CAGR), while a monthly SIP of $500.00 over 5 years (total invested: $30500.00) would be worth $30709.58 (+0.7% absolute return). You can test custom amounts and holding periods in the interactive calculator above.